Drugs / anti-CLL-1 CAR NK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06307054 | Apr 2024 → Mar 2026 overdue | acute myeloid leukemia | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-CLL-1 CAR NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06307054 ↗ |
| Modality | Cell therapy | “anti-human CLL-1 CAR-NK Cells” NCT06307054 ↗ |